Skip to content

Application of Radiomics in Precise Preoperative Diagnosis and Prognsis Evaluation of Colorectal Cancer.

Application of Radiomics in Precise Preoperative Diagnosis and Prognsis Evaluation of Colorectal Cancer: a Prospective, Clinical Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03787667
Enrollment
2000
Registered
2018-12-26
Start date
2018-05-01
Completion date
2020-12-31
Last updated
2018-12-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer Stage I-IV

Brief summary

This is a prospective, clinical study. This study is to collect and analyze data of radiomics of primary site or metastasis of colorectal cancer aiming to precisizing preoperative diagnosis and long-term prognsis evaluation.

Interventions

DIAGNOSTIC_TESTCT or MRI based Radiomics

Radiomic features were extracted from enhanced CT or MRI of colorectal cancer.

Sponsors

Fudan University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Patients with pathologically confirmed colorectal cancer * Male or female aged 18-75 years old on the day of signing informed consent. * Patients who received imageological examination of primary or metastasis * Patients who received surgical resection of primary or metastasis * Patients must have a performance status of ≤1 on the ECOG Performance Scale. * Colorectal cancer is the only malignant tumor * Written informed consent must be obtained from patient or patient's legal representative and ability for patient to comply with the requirements of the study

Exclusion criteria

* Patients received adjuvant treatment prior to imageological examination * Tis stage patients * Paitents who diagnosed with malignant disease within 5 years. * Patients with a history or current evidence of any condition or abnormality that might confound the results of the study, interfere with the patient's participation for the full duration of the study, or is not in the best interest of the patient to participate, in the opinion of the Investigator.

Design outcomes

Primary

MeasureTime frameDescription
Sensitivity2 yearsThe sensitivity of radiomics in predicting regional or distant synchronous colorectal metastasis

Countries

China

Contacts

Primary ContactGuoxiang Cai, M.D.Ph.D.
gxcai@fudan.edu.cn+86 13611831623

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026